Target intelligence / Profile preview

Surfeit locus protein 2 (SURF2)

Target
SURF2
Molecular classification
Other (member of surfeit gene family; not a receptor, enzyme, transporter, GPCR, ion channel, transcription factor, or histone modification protein)
01

Overview

Surfeit locus protein 2 (SURF2) is a highly conserved protein encoded by the SURF2 gene in humans, located on chromosome 9q34.2, and is a member of the surfeit gene family[1][4][12]. SURF2 shares a bidirectional promoter with SURF1 and is expressed in a variety of tissues. Functionally, SURF2 interacts with beta-1,4-Gal-T3, uPAR, and WDR20, and acts as a key modulator of nucleolar stress response by binding free 5S ribonucleoprotein particles (5S RNP) but is not directly involved in ribosome assembly[2]. SURF2 buffers 5S RNP activity under basal conditions to prevent unnecessary activation of nucleolar stress, and its expression is implicated in tumorigenesis by influencing p53 activation during cellular stress[2]. Its precise function is not fully elucidated and no drugs or small molecules are documented to target SURF2 directly[2][10]. Additional notes & clarification: - SURF2 is not a classical therapeutic target such as a receptor, enzyme, transporter, or channel. It is best described as a *modulatory scaffold protein* involved in protein–RNA complex interactions[2][10]. - No known drugs, biomarkers, or safety concerns are directly associated with SURF2 as of current knowledge[2][10]. - Molecular and clinical understanding is still evolving, but increased expression and negative correlations with patient survival in certain cancers (e.g., adrenocortical carcinoma) have been documented, suggesting a possible disease relevance, though not yet as a direct drug target[2].

Other names
Surfeit 2Surf-2surfeit locus protein 2SURF-2
02

Biological functions

Modulation of nucleolar stress responseInteracts with ribonucleoprotein complexes (5S RNP, RPL5, RPL11)May be involved in regulation of p53 activationProtein-protein interaction scaffold
03

Disease associations

Cancer (upregulation in various cancers; negative correlation with survival in adrenocortical cancer)Other (data on additional disease roles are limited)

Beyond the preview

Go deeper on Surfeit locus protein 2 (SURF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Surfeit locus protein 2 (SURF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call